Skip to main content
. 2020 Apr 8;34(3):1272–1281. doi: 10.1111/jvim.15768

FIGURE 2.

FIGURE 2

Comparison of time to progression (TTP) between dogs receiving surgery and adjuvant treatment with toceranib phosphate (TOC) and those receiving surgery alone. The hazard ratio of the surgery and TOC group versus the surgery alone group was 0.82 (95% CI, 0.65‐0.96; P = .02)